Back to search

United States· US:36000-262_29fe8860-4376-4fe2-ab33-e008e94ddd67

Dexmedetomidine Hydrochloride

A dexmedetomidine product containing dexmedetomidine hydrochloride, registered in United States by Baxter Healthcare Corporation. The same ATC class is registered in 17 of our 19 countries.

ATC N05CM18

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDexmedetomidine HydrochlorideATCN05CM18REGISTER NO.US:36000-262_29fe8860…PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Dexmedetomidine is registered in 17 of 19 countries.

Countries holding a registration under ATC N05CM18 (dexmedetomidine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Dexmedetomidine · ATC N05CM18

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DEXMEDETOMIDINE HYDROCHLORIDE
Manufacturer
Baxter Healthcare Corporation
Country
United States (US)
ATC code
N05CM18
ATC class
Dexmedetomidine
Defined daily dose
1 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 3

  • ndc11
    36000-262-05
  • ndc11
    36000-262-10
  • ndc11
    36000-262-25

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

79 interactions on record for dexmedetomidine.

Graded by severity as the source publishes them — 60 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dexmedetomidine · interactions on record

79 records

  • 60 moderate
  • 19 info

Most severe, free to view

  • PapaverineA03AD01moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dexmedetomidine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexmedetomidine products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Dexmedetomidin Altan, Dexmedetomidin Altan Pharmaceuticals, S.A.
  • Belgium · Dexmedetomidine A.Forall, Dexmedetomidine Baxter
  • Bulgaria · Dexmedetomidine Ever Valinject, Dexmedetomidine Kalceks
  • Cyprus · Dexmedetomidine Baxter, Dexmedetomidine Ever Valinject
  • Czechia · Dexmedetomidine B. Braun, Dexmedetomidine Ever Pharma
  • Germany · Dexmedetomidin B. Braun, Dexmedetomidin Baxter
  • Denmark · Dexmedetomidin Kalceks, Dexmedetomidin Viatris
  • Estonia · Dexmedetomidine Auxilia, Dexmedetomidine Kabi
  • Spain · Dexmedetomidina Altan, Dexmedetomidina B. Braun
  • Finland · Dexmedetomidine B. Braun, Dexmedetomidine Baxter
  • France · Dexmedetomidine Altan, Dexmedetomidine Ever Pharma
  • United Kingdom (Northern Ireland) · Dexmedetomidine 100 Micrograms/Ml Concentrate For Solution For Infusion, Dexmedetomidine Altan Pharma
  • Greece · Dexmedetomidine /Kabi, Dexmedetomidine Ariti
  • Croatia · Deksmedetomidin Kabi, Deksmedetomidin Kalceks
  • Hungary · Dexmedetomidin Ever Pharma, Dexmedetomidine Kabi
  • Ireland · Dexmedetomidine As Kalceks, Dexmedetomidine B. Braun
  • Iceland · Dexdor, Dexmedetomidine Rph Pharma
  • Italy · Dexmedetomidina Galenica Senese, Dexmedetomidina Hikma
  • Liechtenstein · Dexdor
  • Lithuania · Dexmedetomidine Kabi, Dexmedetomidine Kalceks
  • Luxembourg · Dexmedetomidine Baxter, Dexmedetomidine Kabi
  • Latvia · Dexmedetomidine Kalceks, Dexmedetomidine Pharmidea
  • Malta · Dexmedetomidine Ever Valinject
  • Netherlands · Dexmedetomidine Altan Pharmaceuticals, S.A., Dexmedetomidine B. Braun
  • Norway · Dexdor, Dexmedetomidine B. Braun
  • Poland · Dexmedetomidine Ever Pharma, Dexmedetomidine Farmak
  • Portugal · Dexmedetomidina A.Forall, Dexmedetomidina Acure
  • Romania · Dexmedetomidină Kabi, Dexmedetomidină Kalceks
  • Sweden · Dexmedetomidine B. Braun, Dexmedetomidine Baxter
  • Slovenia · Deksmedetomidin Kalceks, Deksmedetomidin Viatris
  • Slovakia · Dexmedetomidine B. Braun, Dexmedetomidine Ever Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eca5786d-47ef-41fd-a8b4-d544c7c866bd
GET /v1/drugs/eca5786d-47ef-41fd-a8b4-d544c7c866bd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "100",
  "substance": "DEXMEDETOMIDINE HYDROCHLORIDE",
  "productndc": "36000-262",
  "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
  "dea_schedule": null,
  "strength_unit": "ug/mL",
  "application_number": "ANDA208103",
  "marketing_category": "ANDA"
}

See everything about dexmedetomidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.